カテゴリー： QYResearch, 世界, 医療/バイオ

世界の子癇前症臨床検査市場インサイト及び予測（血液検査、尿検査）

◆英語タイトル：Global Preeclampsia Laboratory Testing Market Insights, Forecast to 2028
	◆商品コード：QY22JLX09279 ◆発行会社（リサーチ会社）：QYResearch ◆発行日：2022年7月（※2025年版があります。お問い合わせください。） ◆ページ数：108 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後3営業日） ◆調査対象地域：グローバル ◆産業分野：医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD4,900 ⇒換算￥744,800	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD7,350 ⇒換算￥1,117,200	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD9,800 ⇒換算￥1,489,600	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、子癇前症臨床検査のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に子癇前症臨床検査の世界市場のxxx％を占める「血液検査」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院・クリニック」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
子癇前症臨床検査の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの子癇前症臨床検査市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

子癇前症臨床検査のグローバル主要企業には、PerkinElmer Inc.、F. Hoffmann-La Roche Ltd.、ThermoFischer Scientific Inc.、SERA Prognostics、Bayer AG,、Siemens Healthineers AG、Metabolomic Diagnostics Ltd.、DiabetOmics Inc.,、DRG INSTRUMENTS GMBH、Progenity Inc.などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

子癇前症臨床検査市場は、種類と用途によって区分されます。世界の子癇前症臨床検査市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
血液検査、尿検査

【用途別セグメント】
病院・クリニック、診断センター、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 子癇前症臨床検査製品概要
- 種類別市場（血液検査、尿検査）
- 用途別市場（病院・クリニック、診断センター、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の子癇前症臨床検査販売量予測2017-2028
- 世界の子癇前症臨床検査売上予測2017-2028
- 子癇前症臨床検査の地域別販売量
- 子癇前症臨床検査の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別子癇前症臨床検査販売量
- 主要メーカー別子癇前症臨床検査売上
- 主要メーカー別子癇前症臨床検査価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（血液検査、尿検査）
- 子癇前症臨床検査の種類別販売量
- 子癇前症臨床検査の種類別売上
- 子癇前症臨床検査の種類別価格
・用途別市場規模（病院・クリニック、診断センター、その他）
- 子癇前症臨床検査の用途別販売量
- 子癇前症臨床検査の用途別売上
- 子癇前症臨床検査の用途別価格
・北米市場
- 北米の子癇前症臨床検査市場規模（種類別、用途別）
- 主要国別の子癇前症臨床検査市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの子癇前症臨床検査市場規模（種類別、用途別）
- 主要国別の子癇前症臨床検査市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の子癇前症臨床検査市場規模（種類別、用途別）
- 主要国別の子癇前症臨床検査市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の子癇前症臨床検査市場規模（種類別、用途別）
- 主要国別の子癇前症臨床検査市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの子癇前症臨床検査市場規模（種類別、用途別）
- 主要国別の子癇前症臨床検査市場規模（トルコ、サウジアラビア）
・企業情報
PerkinElmer Inc.、F. Hoffmann-La Roche Ltd.、ThermoFischer Scientific Inc.、SERA Prognostics、Bayer AG,、Siemens Healthineers AG、Metabolomic Diagnostics Ltd.、DiabetOmics Inc.,、DRG INSTRUMENTS GMBH、Progenity Inc.
・産業チェーン及び販売チャネル分析
- 子癇前症臨床検査の産業チェーン分析
- 子癇前症臨床検査の原材料
- 子癇前症臨床検査の生産プロセス
- 子癇前症臨床検査の販売及びマーケティング
- 子癇前症臨床検査の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 子癇前症臨床検査の産業動向
- 子癇前症臨床検査のマーケットドライバー
- 子癇前症臨床検査の課題
- 子癇前症臨床検査の阻害要因
・主な調査結果

Market Analysis and Insights: Global Preeclampsia Laboratory Testing Market
The global Preeclampsia Laboratory Testing market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Blood Tests accounting for % of the Preeclampsia Laboratory Testing global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals and Clinics segment is altered to an % CAGR throughout this forecast period.
China Preeclampsia Laboratory Testing market size is valued at US$ million in 2021, while the North America and Europe Preeclampsia Laboratory Testing are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Preeclampsia Laboratory Testing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Preeclampsia Laboratory Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Preeclampsia Laboratory Testing market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Preeclampsia Laboratory Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Preeclampsia Laboratory Testing market.
Global Preeclampsia Laboratory Testing Scope and Market Size
Preeclampsia Laboratory Testing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Preeclampsia Laboratory Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Blood Tests
Urine Tests
Segment by Application
Hospitals and Clinics
Diagnostics Centers
Others
By Company
PerkinElmer Inc.
F. Hoffmann-La Roche Ltd.
ThermoFischer Scientific Inc.
SERA Prognostics
Bayer AG,
Siemens Healthineers AG
Metabolomic Diagnostics Ltd.
DiabetOmics Inc.,
DRG INSTRUMENTS GMBH
Progenity Inc.
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preeclampsia Laboratory Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Blood Tests
1.2.3 Urine Tests
1.3 Market by Application
1.3.1 Global Preeclampsia Laboratory Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals and Clinics
1.3.3 Diagnostics Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Preeclampsia Laboratory Testing Market Perspective (2017-2028)
2.2 Preeclampsia Laboratory Testing Growth Trends by Region
2.2.1 Preeclampsia Laboratory Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Preeclampsia Laboratory Testing Historic Market Size by Region (2017-2022)
2.2.3 Preeclampsia Laboratory Testing Forecasted Market Size by Region (2023-2028)
2.3 Preeclampsia Laboratory Testing Market Dynamics
2.3.1 Preeclampsia Laboratory Testing Industry Trends
2.3.2 Preeclampsia Laboratory Testing Market Drivers
2.3.3 Preeclampsia Laboratory Testing Market Challenges
2.3.4 Preeclampsia Laboratory Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Preeclampsia Laboratory Testing Players by Revenue
3.1.1 Global Top Preeclampsia Laboratory Testing Players by Revenue (2017-2022)
3.1.2 Global Preeclampsia Laboratory Testing Revenue Market Share by Players (2017-2022)
3.2 Global Preeclampsia Laboratory Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Preeclampsia Laboratory Testing Revenue
3.4 Global Preeclampsia Laboratory Testing Market Concentration Ratio
3.4.1 Global Preeclampsia Laboratory Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preeclampsia Laboratory Testing Revenue in 2021
3.5 Preeclampsia Laboratory Testing Key Players Head office and Area Served
3.6 Key Players Preeclampsia Laboratory Testing Product Solution and Service
3.7 Date of Enter into Preeclampsia Laboratory Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Preeclampsia Laboratory Testing Breakdown Data by Type
4.1 Global Preeclampsia Laboratory Testing Historic Market Size by Type (2017-2022)
4.2 Global Preeclampsia Laboratory Testing Forecasted Market Size by Type (2023-2028)
5 Preeclampsia Laboratory Testing Breakdown Data by Application
5.1 Global Preeclampsia Laboratory Testing Historic Market Size by Application (2017-2022)
5.2 Global Preeclampsia Laboratory Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Preeclampsia Laboratory Testing Market Size (2017-2028)
6.2 North America Preeclampsia Laboratory Testing Market Size by Type
6.2.1 North America Preeclampsia Laboratory Testing Market Size by Type (2017-2022)
6.2.2 North America Preeclampsia Laboratory Testing Market Size by Type (2023-2028)
6.2.3 North America Preeclampsia Laboratory Testing Market Share by Type (2017-2028)
6.3 North America Preeclampsia Laboratory Testing Market Size by Application
6.3.1 North America Preeclampsia Laboratory Testing Market Size by Application (2017-2022)
6.3.2 North America Preeclampsia Laboratory Testing Market Size by Application (2023-2028)
6.3.3 North America Preeclampsia Laboratory Testing Market Share by Application (2017-2028)
6.4 North America Preeclampsia Laboratory Testing Market Size by Country
6.4.1 North America Preeclampsia Laboratory Testing Market Size by Country (2017-2022)
6.4.2 North America Preeclampsia Laboratory Testing Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Preeclampsia Laboratory Testing Market Size (2017-2028)
7.2 Europe Preeclampsia Laboratory Testing Market Size by Type
7.2.1 Europe Preeclampsia Laboratory Testing Market Size by Type (2017-2022)
7.2.2 Europe Preeclampsia Laboratory Testing Market Size by Type (2023-2028)
7.2.3 Europe Preeclampsia Laboratory Testing Market Share by Type (2017-2028)
7.3 Europe Preeclampsia Laboratory Testing Market Size by Application
7.3.1 Europe Preeclampsia Laboratory Testing Market Size by Application (2017-2022)
7.3.2 Europe Preeclampsia Laboratory Testing Market Size by Application (2023-2028)
7.3.3 Europe Preeclampsia Laboratory Testing Market Share by Application (2017-2028)
7.4 Europe Preeclampsia Laboratory Testing Market Size by Country
7.4.1 Europe Preeclampsia Laboratory Testing Market Size by Country (2017-2022)
7.4.2 Europe Preeclampsia Laboratory Testing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Preeclampsia Laboratory Testing Market Size (2017-2028)
8.2 Asia-Pacific Preeclampsia Laboratory Testing Market Size by Type
8.2.1 Asia-Pacific Preeclampsia Laboratory Testing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Preeclampsia Laboratory Testing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Preeclampsia Laboratory Testing Market Share by Type (2017-2028)
8.3 Asia-Pacific Preeclampsia Laboratory Testing Market Size by Application
8.3.1 Asia-Pacific Preeclampsia Laboratory Testing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Preeclampsia Laboratory Testing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Preeclampsia Laboratory Testing Market Share by Application (2017-2028)
8.4 Asia-Pacific Preeclampsia Laboratory Testing Market Size by Region
8.4.1 Asia-Pacific Preeclampsia Laboratory Testing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Preeclampsia Laboratory Testing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Preeclampsia Laboratory Testing Market Size (2017-2028)
9.2 Latin America Preeclampsia Laboratory Testing Market Size by Type
9.2.1 Latin America Preeclampsia Laboratory Testing Market Size by Type (2017-2022)
9.2.2 Latin America Preeclampsia Laboratory Testing Market Size by Type (2023-2028)
9.2.3 Latin America Preeclampsia Laboratory Testing Market Share by Type (2017-2028)
9.3 Latin America Preeclampsia Laboratory Testing Market Size by Application
9.3.1 Latin America Preeclampsia Laboratory Testing Market Size by Application (2017-2022)
9.3.2 Latin America Preeclampsia Laboratory Testing Market Size by Application (2023-2028)
9.3.3 Latin America Preeclampsia Laboratory Testing Market Share by Application (2017-2028)
9.4 Latin America Preeclampsia Laboratory Testing Market Size by Country
9.4.1 Latin America Preeclampsia Laboratory Testing Market Size by Country (2017-2022)
9.4.2 Latin America Preeclampsia Laboratory Testing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Preeclampsia Laboratory Testing Market Size (2017-2028)
10.2 Middle East & Africa Preeclampsia Laboratory Testing Market Size by Type
10.2.1 Middle East & Africa Preeclampsia Laboratory Testing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Preeclampsia Laboratory Testing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Preeclampsia Laboratory Testing Market Share by Type (2017-2028)
10.3 Middle East & Africa Preeclampsia Laboratory Testing Market Size by Application
10.3.1 Middle East & Africa Preeclampsia Laboratory Testing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Preeclampsia Laboratory Testing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Preeclampsia Laboratory Testing Market Share by Application (2017-2028)
10.4 Middle East & Africa Preeclampsia Laboratory Testing Market Size by Country
10.4.1 Middle East & Africa Preeclampsia Laboratory Testing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Preeclampsia Laboratory Testing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 PerkinElmer Inc.
11.1.1 PerkinElmer Inc. Company Details
11.1.2 PerkinElmer Inc. Business Overview
11.1.3 PerkinElmer Inc. Preeclampsia Laboratory Testing Introduction
11.1.4 PerkinElmer Inc. Revenue in Preeclampsia Laboratory Testing Business (2017-2022)
11.1.5 PerkinElmer Inc. Recent Developments
11.2 F. Hoffmann-La Roche Ltd.
11.2.1 F. Hoffmann-La Roche Ltd. Company Details
11.2.2 F. Hoffmann-La Roche Ltd. Business Overview
11.2.3 F. Hoffmann-La Roche Ltd. Preeclampsia Laboratory Testing Introduction
11.2.4 F. Hoffmann-La Roche Ltd. Revenue in Preeclampsia Laboratory Testing Business (2017-2022)
11.2.5 F. Hoffmann-La Roche Ltd. Recent Developments
11.3 ThermoFischer Scientific Inc.
11.3.1 ThermoFischer Scientific Inc. Company Details
11.3.2 ThermoFischer Scientific Inc. Business Overview
11.3.3 ThermoFischer Scientific Inc. Preeclampsia Laboratory Testing Introduction
11.3.4 ThermoFischer Scientific Inc. Revenue in Preeclampsia Laboratory Testing Business (2017-2022)
11.3.5 ThermoFischer Scientific Inc. Recent Developments
11.4 SERA Prognostics
11.4.1 SERA Prognostics Company Details
11.4.2 SERA Prognostics Business Overview
11.4.3 SERA Prognostics Preeclampsia Laboratory Testing Introduction
11.4.4 SERA Prognostics Revenue in Preeclampsia Laboratory Testing Business (2017-2022)
11.4.5 SERA Prognostics Recent Developments
11.5 Bayer AG,
11.5.1 Bayer AG, Company Details
11.5.2 Bayer AG, Business Overview
11.5.3 Bayer AG, Preeclampsia Laboratory Testing Introduction
11.5.4 Bayer AG, Revenue in Preeclampsia Laboratory Testing Business (2017-2022)
11.5.5 Bayer AG, Recent Developments
11.6 Siemens Healthineers AG
11.6.1 Siemens Healthineers AG Company Details
11.6.2 Siemens Healthineers AG Business Overview
11.6.3 Siemens Healthineers AG Preeclampsia Laboratory Testing Introduction
11.6.4 Siemens Healthineers AG Revenue in Preeclampsia Laboratory Testing Business (2017-2022)
11.6.5 Siemens Healthineers AG Recent Developments
11.7 Metabolomic Diagnostics Ltd.
11.7.1 Metabolomic Diagnostics Ltd. Company Details
11.7.2 Metabolomic Diagnostics Ltd. Business Overview
11.7.3 Metabolomic Diagnostics Ltd. Preeclampsia Laboratory Testing Introduction
11.7.4 Metabolomic Diagnostics Ltd. Revenue in Preeclampsia Laboratory Testing Business (2017-2022)
11.7.5 Metabolomic Diagnostics Ltd. Recent Developments
11.8 DiabetOmics Inc.,
11.8.1 DiabetOmics Inc., Company Details
11.8.2 DiabetOmics Inc., Business Overview
11.8.3 DiabetOmics Inc., Preeclampsia Laboratory Testing Introduction
11.8.4 DiabetOmics Inc., Revenue in Preeclampsia Laboratory Testing Business (2017-2022)
11.8.5 DiabetOmics Inc., Recent Developments
11.9 DRG INSTRUMENTS GMBH
11.9.1 DRG INSTRUMENTS GMBH Company Details
11.9.2 DRG INSTRUMENTS GMBH Business Overview
11.9.3 DRG INSTRUMENTS GMBH Preeclampsia Laboratory Testing Introduction
11.9.4 DRG INSTRUMENTS GMBH Revenue in Preeclampsia Laboratory Testing Business (2017-2022)
11.9.5 DRG INSTRUMENTS GMBH Recent Developments
11.10 Progenity Inc.
11.10.1 Progenity Inc. Company Details
11.10.2 Progenity Inc. Business Overview
11.10.3 Progenity Inc. Preeclampsia Laboratory Testing Introduction
11.10.4 Progenity Inc. Revenue in Preeclampsia Laboratory Testing Business (2017-2022)
11.10.5 Progenity Inc. Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の子癇前症臨床検査市場インサイト及び予測（血液検査、尿検査）(Global Preeclampsia Laboratory Testing Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の子癇前症臨床検査市場インサイト及び予測（血液検査、尿検査）

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp